Co-Located Conference AgendasDrug Discovery India 2014 | Drug Metabolism & Discovery ADMET | Indian Lab Automation |
Thursday, 11 September 201408:00 | Registration | 09:15 | Inauguration | 09:20 | Chairman's Welcome and Inaugural Talk | 09:30 | Renaissance in Pharmacognosy:The Need is Great and the Time is Now Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America
| 10:15 | Memento Presentation | 10:25 | Coffee Break and Networking in Exhibition Area | 10:55 | | Keynote Presentation Hall 1- Novel Anti-Inflammatory Scaffolds through Sustainable Chemistry Asit Chakraborti, Professor and Head, National Institute of Pharmaceutical Education and Research, India
|
| 10:55 | | Keynote Presentation Hall 2- Understanding the Principles for harnessing Key Phosphate Hydrolysis Step in DNA and RNA complexes with Enzymes. Jyoti Chattopadhyaya, Professor, Uppsala University, Sweden
|
| 11:30 | Hall 1- Novel Heterocyclic Construction Using N-Heterocyclic Carbene Organocatalysis Akkattu Biju, Senior Scientist, National Chemical Laboratory, India
| 11:30 | Hall 2- A Novel Approach to Rescue the Neurodegenerative Diseases with the Modified Peptides Derived from Neuron Specific Kinase (Cdk5) Harish Pant, Senior Investigator, National Institute of Health, United States of America
| 12:00 | Hall 1- DNA-Targeted Anticancer Agents: Molecular Design and their Synthesis N Shankaraiah, Assistant Professor, NIPER, Hyderabad, India
| 12:00 | Hall 2- Chemical Biology Approaches for Target Identification in "Activity Based Proteomic Profiling" Session Maria Costi, Professor, University of Modena and Reggio Emilia, Italy
| 12:30 | Technology Spotlight: Hall 2: Using Protein Design Tools to Guide Pharmacophore Generation and Screening Anand Krishnamurthy, Senior Scientist, Accelrys-BIOVIA
| 12:30 | Hall 1- Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy, India
| 12:45 | | Keynote Presentation Hall 2: Integrative Medicine: A Roadmap of Epigenetic Modulation in Health, Diseases Prevention, and Cure Krishna Banaudha, Associate Professor, The George Washington University, United States of America
|
| 13:00 | Technology Spotlight: Hall 1: Drug Discovery & Development: The dilemma of Investing in Software Solutions K K Bhagchandani, Director, Advanced Chemistry Development Inc
| 13:15 | Hall1: Lunch and Networing in the Exhibition Area | 13:20 | Hall 2- Rethinking Drug Discovery: Going-in for Signaling Pathways and Novel Chemical Space to Hunt for Next Generation Functional Small Molecules Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences, India
| 13:50 | Hall 2: Lunch and Networking in the Exhibition Area | 14:15 | | Keynote Presentation Hall 1- Collaborative Drug Research in India: Opportunity and Challenges in Global Perspectives" Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India
|
| 14:30 | Hall 2- Drugs through Mimicking the Actions of Glycosaminoglycans - Anticoagulants, AntiEmphysema/COPD and Anti-Cancer Stem Cells Umesh Desai, Professor, Virginia Commonwealth University, United States of America
| 14:50 | Hall 1: Dundee, Drug Discovery Unit: Novel Targets and Small Molecule Inhibitors Ian Gilbert, Head of Chemistry, University of Dundee, United Kingdom
| 15:00 | Technology Spotlight: Hall 2: Maximising Value and Success with Automation Lesley Schultz, Product Manager, Agilent Technologies
| 15:15 | Hall 2-Special Lecture: Protein Ubiquitination Enzymes as Novel Cancer Therapeutic Targets Amit Banerjee, Professor, Wayne State University , United States of America
| 15:20 | Hall 1: Coffee Break and Networking in Exhibition Area | 15:40 | | Keynote Presentation Hall 1- Modeling Specificity in Lead Optimization G Sastry, Scientist and Head, Indian Institute of Chemical Technology, India
|
| 16:15 | Hall 1- Open-Source Chemoinformatics for virtual screening in Drug Discovery Muthukumarasamy Karthikeyan, Principal Scientist, National Chemical Laboratory, India
| 16:15 | Hall 2- Advances in Developing Tankyrase Selective Inhibitors Stefan Krauss, Director, University Of Oslo, Norway
| 16:45 | Hall 1- Pharmacophore Modeling and Molecular Docking Based Thriving Protocol for Target Identification Vijay Masand, Assistant Professor, Vidya Bharti College, India
| 16:45 | Hall 2- Molecular Methods that Enable Targeted Therapeutics and Precision Medicine Manohar Furtado, Founder and President, Biology For Global Good Consulting Llc, United States of America
| 17:15 | End of First Day of Conference | 17:30 | FREE WORKSHOP: RNA Silencing in Drug Discovery- Challenges and Strategies |
Friday, 12 September 201409:00 | | Keynote Presentation Hall 1- Reverse Pharmacology (RP) - a Paradigm Shift- for Drug Discovery and Development Ashok Vaidya, Research Director, Kasturba Health Society, India
|
| 09:30 | Hall 2- Plenary Talk: Bioprocessing of Human Pluripotent Stem Cells using CompacT SelecT Cell Culture Automation Yacine Laabi, Research Group Leader, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, France
| 09:35 | Hall 1- Special Lecture: Moving from Single Drug to Formulation Discovery Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India
| 10:00 | Hall 2- Stem Cell Based Chip Platforms In Drug Discovery Subadra Dravida, Founder CEO, Tran-Scell Biologics Pvt. Ltd., India
| 10:05 | Hall 1- Natural Products for Drug Discovery and Development: Inspiration from the “Ancient Wisdom of Mother Nature" Mukund Chorghade, President & CSO, Chorghade Enterprises, United States of America
| 10:30 | Technology Spotlight: Hall 2: Fluent™ Laboratory Automation Solution for Cell-Based Assays Roland Durner, Global Head of LSB Distributors, Tecan Trading AG
| 10:35 | Hall 1:Coffee Break and Networking in Exhibition Area | 10:45 | Hall 2: Coffee Break and Networking in Exhibition Area | 10:55 | Hall 1- "NMITLI Arthritis Model" (Validating Ayurvedic Drugs for Global Use). Arvind Chopra, Director and Chief Rheumatologist, Center for Rheumatic Diseases, India
| 11:05 | Hall 2- Annotating Biological Activities Of Drugs, Natural Products, And Environmental Toxicants by FACTORIAL™ Pathway Profiling Assays Sergei Makarov, Chief Executive Officer, Attagene Inc, United States of America
| 11:25 | Hall 1- Natural Products as New Sources of Drug and Nutraceutical Discovery Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd, India
| 11:35 | Hall 2- Cell Based Assays in Clinical Diagnostics: Applications to Neutralizing Antibody Assays, Pharmacogenomics, and Personalized Medicine John Watson, Director, Promega Corporation, United States of America
| 11:55 | Hall 1- Plenary Talk: High-throughput in vivo Vertebrate Screening: an Automation Point of View Giancarlo Basile, Editor in Chief, Current Research in Drug Discovery, Italy
| 12:05 | Hall 2- Optimisation of New Trypanosoma brucei Inhibitors Raphael Rahmani, Research Fellow, Monash University, Australia
| 12:25 | Hall 1- Discovery of Novel Compounds for the Treatment of Drug Resistant and Persistent Tuberculosis Rajkumar Halder, Scientist E, Translational Health Science and Technology Institute, India
| 12:35 | Hall 2- Repositioning of Drugs-Structure-Based Approach towards Finding New Leads as Antileishmanial Agents Sanjay Batra, Principal Scientist, CSIR Central Drug Research Institute, India
| 12:55 | Hall 1- High Content Image- Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Multiple Highly Pathogenic RNA Viruses Krishna Kota, Scientist, PerkinElmer, United States of America
| 13:05 | Hall 2- Special Lecture: Natural Products Repurposing for Cancer Therapy Petr Bartunek, Group Leader, Academy of Sciences of the Czech Republic, Czech Republic
| 13:25 | Technology Spotlight: Hall 1: Leveraging the Power of High Throughput Screening to Identify a Diastereomeric Salt for Chiral Resolution David Yamane, Product Marketing Director, Freeslate Inc
| 13:40 | Hall 2: Lunch and Networking in Exhibition Area | 13:40 | Hall 1:Lunch and Networking in the Exhibition Area | 14:20 | POSTER EVALUATION | 14:40 | Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery, United States of America
| 15:10 | Opportunities for Strategic Research Partnerships in Drug Discovery Ajith Kamath, Head, Pfizer Inc, India
| 15:40 | Crowdsourcing Systems Level Platform for Open Source Drug Discovery Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit, India
| 16:00 | Open Source Drug Discovery for Tuberculosis: Lessons to learn Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India
| 16:20 | Open Discussion on Open Source Drug Discovery | 16:40 | Coffee Break and Networking in Exhibition Area | 16:55 | Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020 | 17:30 | End of the Conference |
|